HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

FGF-23 and sFRP-4 in chronic kidney disease and post-renal transplantation.

AbstractBACKGROUND:
The phosphatonins fibroblast growth factor-23 (FGF-23) and FRP-4 are inhibitors of tubular phosphate reabsorption that may play a role in the hyperphosphatemia associated with chronic kidney disease (CKD) or in the hypophosphatemia associated with renal transplants.
METHODS:
Plasma FGF-23, FRP-4, phosphorus and parathyroid hormone were measured in patients at all stages of CKD. Phosphate regulation of FGF-23 and secreted frizzled related protein-4 (sFRP-4) was examined in end-stage renal disease patients in the presence and absence of therapeutic phosphate binder usage. In renal transplant patients, plasma FGF-23, sFRP-4 and phosphorus concentrations were determined before and 4-5 days after transplantation.
RESULTS:
Plasma FGF-23 correlated with creatinine clearance (r2 = -0.584, p < 0.0001) and plasma phosphorus (r2 = 0.347, p < 0.001) in CKD patients and with plasma phosphorus (r2 = 0.448, p < 0.001) in end-stage renal disease patients. Phosphate binder withdrawal increased FGF-23 levels. In kidney transplant patients, dramatic decreases in FGF-23 (-88.8 +/- 5.4%) and phosphorus (-64 +/- 10.2%) were observed by 4-5 days post-transplantation. In patients with post-transplant hypophosphatemia, FGF-23 levels correlated inversely with plasma phosphorus (r2 = 0.661, p < 0.05). sFRP-4 levels did not change with creatinine clearance or hyperphosphatemia in CKD or end-stage renal disease patients, and no relation was noted between post-transplant sFRP-4 levels and hypophosphatemia.
CONCLUSIONS:
In CKD, FGF-23 levels rose with decreasing creatinine clearance rates and increasing plasma phosphorus levels, and rapidly decreased post-transplantation suggesting FGF-23 is cleared by the kidney. Residual FGF-23 may contribute to the hypophosphatemia in post-transplant patients.
AuthorsSangeeta Pande, Cynthia S Ritter, Marcos Rothstein, Karen Wiesen, John Vassiliadis, Rajiv Kumar, Susan C Schiavi, Eduardo Slatapolsky, Alex J Brown
JournalNephron. Physiology (Nephron Physiol) Vol. 104 Issue 1 Pg. p23-32 ( 2006) ISSN: 1660-2137 [Electronic] Switzerland
PMID16691036 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • FGF23 protein, human
  • Parathyroid Hormone
  • Phosphates
  • Proto-Oncogene Proteins
  • SFRP4 protein, human
  • Fibroblast Growth Factors
  • Fibroblast Growth Factor-23
Topics
  • Female
  • Fibroblast Growth Factor-23
  • Fibroblast Growth Factors (blood)
  • Humans
  • Hypophosphatemia (blood, metabolism)
  • Kidney Failure, Chronic (blood, metabolism)
  • Kidney Transplantation
  • Kidney Tubules (metabolism)
  • Male
  • Parathyroid Hormone (blood)
  • Phosphates (blood, metabolism)
  • Postoperative Complications (blood)
  • Proto-Oncogene Proteins (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: